TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
LXRX

Lexicon Pharmaceuticals Inc

Healthcare · Biotechnology

1.80$ +0.0% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Lexicon Pharmaceuticals Inc (LXRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 250 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LXRX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
517 476 396 364 329 437 387 333 310 284 259 233 445 418 371 323 179 204 193 172 172 137 136 112 192 194 163 317 276 229 417 373 321 298 298 226 206 185 269 250
399 358 279 247 214 322 273 220 198 173 147 122 364 338 292 246 122 158 145 123 124 89 88 65 139 141 110 264 223 177 365 321 269 246 246 145 123 102 186 197
396 347 260 31 83 311 20 15 49 160 46 106 170 36 56 87 52 126 98 90 92 64 60 21 19 46 26 102 21 22 96 36 35 67 63 21 50 34 38 41
396 347 260 231 197 311 262 210 187 160 133 106 296 272 249 202 111 152 141 119 121 87 87 62 136 138 106 257 218 170 356 310 258 238 195 139 116 96 171 191
0.7 7.5 8.7 5.0 11 4.8 4.5 4.4 2.9 5.9 4.4 5.6 57 57 30 31 1.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.3 1.0 1.5 2.6 2.9 3.5 47 2.2 2.3 2.4 12 1.6
0.0 0.0 0.2 0.8 2.1 1.9 2.1 2.1 4.8 4.7 4.6 4.3 4.5 4.2 4.1 4.0 0.0 0.0 0.0 0.0 0.0 – 0.0 – 0.0 0.0 0.0 0.2 0.3 0.4 0.5 0.6 0.6 0.2 0.2 0.2 0.2 0.3 0.3 1.2
20 19 19 19 18 18 17 17 16 16 15 15 15 14 14 12 11 0.3 0.3 1.2 1.3 1.2 1.1 1.0 0.9 2.1 2.2 2.2 – – – – – – – – – – – –
45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45 45
53 53 53 53 52 52 51 51 51 50 50 49 20 20 19 19 – – – – – – – – – – – – – – – – – – – – – – – –
332 318 262 257 251 384 361 338 340 311 304 298 280 301 316 333 91 47 41 34 36 23 43 41 48 77 75 130 137 136 128 133 143 152 175 96 86 77 66 76
170 165 137 133 129 124 100 81 69 37 28 22 45 65 80 98 79 47 39 33 34 22 19 17 18 23 20 26 32 32 23 28 36 45 111 35 22 21 9.9 15
-16 -16 5.6 4.2 1.9 21 0.7 0.0 -13 -14 1.1 1.1 11 12 11 11 9.2 12 13 13 13 1.1 0.9 0.8 1.4 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.2 43 0.9 1.6 6.2 1.6 1.6
42 53 42 44 53 39 67 50 51 12 14 10 21 12 18 30 12 5.5 4.9 8.5 8.3 9.2 9.3 7.3 9.4 10 10 11 12 14 8.1 12 14 15 11 5.9 3.8 3.1 3.0 2.3
85 85 85 85 86 232 232 232 244 244 244 244 234 234 234 235 12 – – – – – 23 24 24 49 49 99 99 100 100 99 100 100 59 56 57 49 50 51
185 157 135 106 78 52 26 -5.1 -29 -26 -46 -65 165 117 55 -11 88 156 153 137 137 114 93 71 144 117 88 186 140 93 289 240 179 146 123 129 120 108 203 175
-1,218 -1,250 -1,287 -1,322 -1,353 -1,381 -1,409 -1,444 -1,471 -1,472 -1,493 -1,516 -1,290 -1,341 -1,408 -1,477 -1,395 -1,400 -1,421 -1,439 -1,462 -1,488 -1,511 -1,536 -1,559 -1,590 -1,622 -1,667 -1,717 -1,767 -1,815 -1,869 -1,933 -1,967 -1,993 -1,989 -2,002 -2,018 -2,019 -2,050
104 104 104 105 106 106 106 106 106 106 106 106 117 106 107 107 118 122 143 144 146 149 149 150 175 189 189 205 245 245 245 311 361 361 362 364 363 363 400 438

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?